{{Motif
|accession=000094
|aglycon=Cer
|alignment=Whole-Glycan
|collection=GGM
|dbxref=GlycanDictionary:GD2
|displayhgv=false
|glycoct=RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6{{!}}1:a{{!}}2:keto{{!}}3:d
4s:n-acetyl
5b:a-dgro-dgal-NON-2:6{{!}}1:a{{!}}2:keto{{!}}3:d
6s:n-acetyl
7b:b-dgal-HEX-1:5
8s:n-acetyl
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n
4:3o(8+2)5d
5:5d(5+1)6n
6:2o(4+1)7d
7:7d(2+1)8n
|glytoucan=G02657AK
|keyword=Disialylated ganglioside;Glycolipid
|name=GD2
|prefname=GD2
|redend=true
|reference=Cummings (2009) The repertoire of glycan determinants in the human glycome;Cahan et al. (1982) Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside ...;Katano et al. (1984) Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of ...
|sameas=GD.R000401,GDB.002227,GDC.000094,GDH.000057,GDSB.000094,GDV.000071,GE.EP0061,GM.G02657AK,UCM.000057
|wurcs=WURCS{{=}}2.0/4,5,4/{{!(}}a2122h-1b_1-5{{!)}}{{!(}}a2112h-1b_1-5{{!)}}{{!(}}Aad21122h-2a_2-6_5*NCC/3{{=}}O{{!)}}{{!(}}a2112h-1b_1-5_2*NCC/3{{=}}O{{!)}}/1-2-3-3-4/a4-b1_b3-c2_b4-e1_c8-d2
}}
